DK0789558T3 - Anvendelse af væskeformige carbonflourider til at lette pulmonal lægemiddeltilførsel - Google Patents

Anvendelse af væskeformige carbonflourider til at lette pulmonal lægemiddeltilførsel

Info

Publication number
DK0789558T3
DK0789558T3 DK95939052T DK95939052T DK0789558T3 DK 0789558 T3 DK0789558 T3 DK 0789558T3 DK 95939052 T DK95939052 T DK 95939052T DK 95939052 T DK95939052 T DK 95939052T DK 0789558 T3 DK0789558 T3 DK 0789558T3
Authority
DK
Denmark
Prior art keywords
drug delivery
liquid carbon
pulmonary drug
carbon fluorides
facilitate pulmonary
Prior art date
Application number
DK95939052T
Other languages
English (en)
Inventor
Gwen H Rosenberg
Original Assignee
Alliance Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alliance Pharma filed Critical Alliance Pharma
Application granted granted Critical
Publication of DK0789558T3 publication Critical patent/DK0789558T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0082—Lung surfactant, artificial mucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0468—Liquids non-physiological
    • A61M2202/0476—Oxygenated solutions
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S128/00—Surgery
    • Y10S128/913—Breathable liquids

Landscapes

  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK95939052T 1994-11-04 1995-11-02 Anvendelse af væskeformige carbonflourider til at lette pulmonal lægemiddeltilførsel DK0789558T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/334,688 US5531219A (en) 1994-11-04 1994-11-04 Use of liquid fluorocarbons to facilitate pulmonary drug delivery
PCT/US1995/014280 WO1996014056A1 (en) 1994-11-04 1995-11-02 Use of liquid fluorocarbons to facilitate pulmonary drug delivery

Publications (1)

Publication Number Publication Date
DK0789558T3 true DK0789558T3 (da) 2000-03-06

Family

ID=23308353

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95939052T DK0789558T3 (da) 1994-11-04 1995-11-02 Anvendelse af væskeformige carbonflourider til at lette pulmonal lægemiddeltilførsel

Country Status (10)

Country Link
US (1) US5531219A (da)
EP (1) EP0789558B1 (da)
JP (1) JPH10508602A (da)
AT (1) ATE182785T1 (da)
AU (1) AU710381B2 (da)
DE (1) DE69511279T2 (da)
DK (1) DK0789558T3 (da)
ES (1) ES2136315T3 (da)
GR (1) GR3031504T3 (da)
WO (1) WO1996014056A1 (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2124260T3 (es) * 1991-05-03 1999-02-01 Alliance Pharma Respiracion liquida parcial de fluorocarbonos.
US5654007A (en) * 1995-06-07 1997-08-05 Inhale Therapeutic Systems Methods and system for processing dispersible fine powders
US5829428A (en) * 1996-05-29 1998-11-03 Alliance Pharmaceutical Corp. Methods and apparatus for reducing the loss of respiratory promoters
WO1998006426A1 (en) * 1996-08-14 1998-02-19 Gram Joergen Brodersen Use of a plasminogen activator for the treatment of pulmonary disorders
US6451784B1 (en) * 1996-12-30 2002-09-17 Battellepharma, Inc. Formulation and method for treating neoplasms by inhalation
CA2628857C (en) 1996-12-30 2011-09-13 Batelle Memorial Institute Formulation and method for treating neoplasms by inhalation
CN1123345C (zh) * 1997-02-17 2003-10-08 奥坦纳医药公司 治疗ards或irds的组合物
US20040219149A1 (en) * 2001-06-08 2004-11-04 Yuhong Zhou Methods for the modulation of il-13
WO2000075281A2 (en) 1999-06-09 2000-12-14 University Technology Corporation Supercritical fluid-assisted nebulization and bubble drying
EP1379306A1 (de) * 2001-04-11 2004-01-14 Michael Kandler Vorrichtung zur künstlichen beatmung
US7607436B2 (en) * 2002-05-06 2009-10-27 The Research Foundation Of State University Of New York Methods, devices and formulations for targeted endobronchial therapy
CA2413041A1 (fr) * 2002-11-29 2004-05-29 Jean-Paul Praud Un appareil permettant d'effectuer des ventilations liquides totales
GB2422310B (en) * 2004-12-02 2006-12-27 Kaizen Matsumoto Carcinogen solvents in reducing the carcinogen concentration of cells
US7909031B2 (en) * 2005-06-09 2011-03-22 Temple Univesity - Of The Commonwealth System of Higher Education Process for transient and steady state delivery of biological agents to the lung via breathable liquids
WO2007071052A1 (en) * 2005-12-21 2007-06-28 Uti Limited Partnership Treatment of respiratory diseases
US9351943B2 (en) * 2010-07-01 2016-05-31 Matthew T. McLeay Anti-fibroblastic fluorochemical emulsion therapies
EP3065705A4 (en) * 2013-11-04 2017-10-18 Board of Regents, The University of Texas System Compositions and methods for administration of an enzyme to a subject's airway
US9028401B1 (en) 2013-11-11 2015-05-12 Cross Bay Medical, Inc. Apparatus and methods for accessing and sealing bodily vessels and cavities
US10034986B2 (en) 2013-11-11 2018-07-31 Crossbay Medical, Inc. Method and apparatus of tubal patency catheter and delivery systems
US10245074B2 (en) 2013-11-11 2019-04-02 Crossbay Medical, Inc. Apparatus and methods for accessing and sealing bodily vessels and cavities
WO2016179447A1 (en) * 2015-05-06 2016-11-10 Board Of Regents, The University Of Texas System Compositions and methods for administration of an enzyme to a subject's airway
US11318041B2 (en) 2019-10-09 2022-05-03 Crossbay Medical, Inc. Apparatus and method for everting catheter for IUD delivery and placement in the uterine cavity
WO2022081556A1 (en) * 2020-10-12 2022-04-21 Boundless Science, Llc Systems, devices and methods for delivering aerosolized fluorocarbons

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4927623A (en) * 1986-01-14 1990-05-22 Alliance Pharmaceutical Corp. Dissolution of gas in a fluorocarbon liquid
IT1203873B (it) * 1987-04-08 1989-02-23 Chiesi Farma Spa Composizioni farmaceutiche che lo surfattante polmonare naturale, contengono. metodo di preparazione e
US5174988A (en) * 1989-07-27 1992-12-29 Scientific Development & Research, Inc. Phospholipid delivery system
JP2935519B2 (ja) * 1989-08-28 1999-08-16 シーキンス，ケイ・マイケル 超音波および／またはペルフルオロカーボン液での対流を介する肺癌高熱治療
US5437272A (en) * 1991-05-01 1995-08-01 Alliance Pharmaceutical Corp. Perfluorocarbon associated gas exchange
ES2124260T3 (es) * 1991-05-03 1999-02-01 Alliance Pharma Respiracion liquida parcial de fluorocarbonos.
US5209785A (en) * 1991-10-30 1993-05-11 United Technologies Corporation Non-chlorinated solvent dewax process

Also Published As

Publication number Publication date
WO1996014056A1 (en) 1996-05-17
GR3031504T3 (en) 2000-01-31
DE69511279D1 (de) 1999-09-09
US5531219A (en) 1996-07-02
EP0789558A1 (en) 1997-08-20
DE69511279T2 (de) 2000-01-05
ATE182785T1 (de) 1999-08-15
EP0789558B1 (en) 1999-08-04
AU4101796A (en) 1996-05-31
ES2136315T3 (es) 1999-11-16
AU710381B2 (en) 1999-09-16
JPH10508602A (ja) 1998-08-25

Similar Documents

Publication Publication Date Title
DK0789558T3 (da) Anvendelse af væskeformige carbonflourider til at lette pulmonal lægemiddeltilførsel
EE200000194A (et) Perforeeritud mikropartiklid ja nende kasutamise meetodid
EE04002B1 (et) Peroraalne farmatseutiline annusvorm, mis sisaldab prootonpumba inhibiitorit ja antatsiidainet või alginaati
HUP0101293A3 (en) Aspb28-human insulin comprising pharmaceutical composition administered by inhalation and their use
NO955226L (no) Terapautisk preparat for inhalering
WO2006022996A3 (en) Dosage form containing multiple drugs
WO2006016953A3 (en) Bis closed loop anesthetic delivery
ATE236585T1 (de) Vorgefüllte fluidspritze
SV2004001556A (es) Preparaciones acidas de insulina con establidad mejorada
DE69725379D1 (de) Dosiervorrichtung zur Zuführung von zusätzlichem Gas oder Flüssigkeit im Atemgas eines Anästhesie- oder Beatmungsgerätes
CO5060481A1 (es) Suministro de agente activo aerosolizado modulado con resistencia de flujo
EP3494995A3 (en) Formoterol superfine formulation
DE122011000009I1 (de) Verbesserte arzneiverabreichung an schleimhautoberflächen
DK1257254T3 (da) Formuleringer indeholdende et anticholinergt lægemiddel til behandling af kronisk obstruktiv lungesygdom
IL125534A0 (en) A unit dose of budesonide and use thereof for nasal administration
AU6675198A (en) Transdermal drug delivery system for the administration of tamsulosin, and related compositions and methods of use
HUP9904075A2 (hu) Loratidint és egy decongestanst tartalmazó készítmény asztma kezelésére
FI970834A (fi) Kynämäisessä lääkeinjektioruiskussa käytettäväksi tarkoitettu patruunakokoonpano
WO2004028504A8 (en) Modified release dosage forms
DK0799035T3 (da) Emulsion egnet til indgivelse af et sphingolipid og anvendelse deraf
BR9713514A (pt) Novo uso de creatina
CY1105117T1 (el) Θepαπειες για τη χρονια νεφρικη ανεπαρκεια χρησιμοποιωντας ανταγωνιστες των ενσωματινων
ATE256134T1 (de) Sulfatierte phosphatidylinositole, ihre herstellung und verwendung
Noble et al. The possible role of serotonin 5HT2 receptor antagonism in cardioprotection
BR0006237A (pt) Inalador em aerossol, e, processo de tratamentode um sujeito com um agente farmacêutico